MICROBOT MEDICAL INC. - COMMON STOCK

1,9300

10-января-25 15:45:00

15 мин. задержка

Акции

+0,0600

+3,21%

Сегодняшний диапазон

1,7500 - 2,1000

ISIN

N/A

Источник

NASDAQ

Microbot Medical Closes $8.6 Million Registered Direct Offering

10 янв 2025 09:25:51 Источник Nasdaq GlobeNewswire
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

08 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

07 янв 2025 15:15:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

06 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

30 дек 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

10 дек 2024 09:18:37 Источник Nasdaq GlobeNewswire
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System

10 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

15 окт 2024 07:38:00 Источник Nasdaq GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

30 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

17 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

22 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

13 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

01 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

18 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

09 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

08 июл 2024 07:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

03 июл 2024 07:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

20 июн 2024 07:25:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

17 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

04 июн 2024 15:20:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.